|
|
|
Volumn 73, Issue 2, 1998, Pages 105-110
|
|
Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 S CYSTEAMINYLPHENOL;
4 S CYSTEINYLPHENOL;
4-S-CYSTEAMINYLPHENOL;
4-S-CYSTEINYLPHENOL;
ANTINEOPLASTIC AGENT;
CYSTEINE;
DRUG DERIVATIVE;
MELANIN;
MERCAPTAMINE;
MONOPHENOL MONOOXYGENASE;
N ACETYL 4 S CYSTEAMINYLPHENOL;
N-ACETYL-4-S-CYSTEAMINYLPHENOL;
PHENOL DERIVATIVE;
TYROSINE;
ANIMAL;
ARTICLE;
CELL CULTURE;
DNA DAMAGE;
ENZYME SPECIFICITY;
HUMAN;
MELANOMA;
METABOLISM;
MOUSE;
OXIDATIVE STRESS;
SKIN TUMOR;
SYNTHESIS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CYSTEAMINE;
CYSTEINE;
DNA DAMAGE;
HUMANS;
MELANINS;
MELANOMA;
MICE;
MONOPHENOL MONOOXYGENASE;
OXIDATIVE STRESS;
PHENOLS;
SKIN NEOPLASMS;
SUBSTRATE SPECIFICITY;
TUMOR CELLS, CULTURED;
TYROSINE;
|
|
EID: 0032013857
PISSN: 03676102
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
